Life Sciences & Biotechnology

Life Sciences & Biotechnology

Mechanism based approach comprising concomitant administration of chlorogenic acid, a natural JAK/STAT inhibitor with leflunomide (DMARD) for the management of adverse drug reactions and improved efficacy in the treatment of rheumatoid arthritis

Pages

Subscribe to RSS - Life Sciences & Biotechnology